$AMZE

AMAZE HOLDINGS, INC.

CIK:0001880343|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenues	$ 619,621	$ 869,884	$ 1,088,674	$ 930,098
Cost of revenues	76,417	82,372	112,075	145,162
Gross income	543,204	787,512	976,599	784,936
Selling, general and administrative expenses	3,990,912	4,881,391	8,523,094	6,768,134
Equity-based compensation	167,631	190,359	327,214	190,359
Depreciation and amortization	1,050,440	1,674	2,094,026	2,232
Operating loss	(4,665,779)	(4,285,912)	(9,967,735)	(6,175,789)
Other income (expense)
Other income (expense)	(4,391)	(27,379)	16,497	(139)
Interest expense	(67,428)	(684,116)	(205,302)	(924,988)
Realized loss on equity investment		(50,760)		(54,760)
Change in fair value of convertible debt	(27,608)		(287,460)
Gain on extinguishment of liabilities	343,366	0	412,286	18,301
Total other income (expense)	243,939	(762,255)	(63,979)	(961,586)
Net loss	(4,421,840)	(5,048,167)	(10,031,714)	(7,137,375)
Series A preferred dividends		53,433	18,600	109,533
Net loss attributable to common stockholders	$ (4,421,840)	$ (5,101,600)	$ (10,050,314)	$ (7,246,908)
Weighted average shares outstanding
Basic	7,398,863	202,772	5,944,785	146,803
Diluted	7,398,863	202,772	5,944,785	146,803
Net loss per share - basic	$ (0.60)	$ (25.16)	$ (1.69)	$ (49.36)
Net loss per share - diluted	$ (0.60)	$ (25.16)	$ (1.69)	$ (49.36)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities
Net loss	$ (4,421,840)	$ (5,609,874)	$ (5,048,167)	$ (2,089,208)	$ (10,031,714)	$ (7,137,375)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of original issue discount					93,458	699,354
Depreciation and amortization expense	1,050,440		1,674		2,094,026	2,232
Amortization of right of use asset					27,616
Realized loss on equity investment						(54,760)
Change in fair value of convertible notes payable	27,608				287,460
Gain on extinguishment of liabilities	(343,366)		0		(412,286)	(18,301)
Equity-based compensation	167,631		190,359		327,214	190,359
Inventory write-downs					43,712	0
Allowance for doubtful accounts					199,000
Changes in operating assets and liabilities
Accounts receivable						28,801
Inventories					2,883	27,954
Prepaid expenses and other					(57,902)	(270,985)
Interest receivable					(3,925)	(41,293)
Accounts payable					121,600	2,115,073
Accrued compensation					516,968	337,690
Accrued creator commissions					57,911	25,195
Settlement payable					(93,289)	156,405
Accrued expenses					(193,243)	(300,312)
Accrued sales tax					32,927	(32,382)
Deferred revenue					(172,861)	370,064
Operating lease					(15,812)
Net cash used in operating activities					(7,176,257)	(3,902,281)
Cash flows from investing activities
Cash acquired through acquisition (Note 2)						591,686
Capitalized internally developed software					(271,427)
Intangible asset acquired in Kast acquisition					(210,430)
Issuance of note receivable						(900,000)
Net cash used in investing activities					(481,857)	(308,314)
Cash flows from financing activities
Proceeds from debt, net of issuance costs						2,488,241
Proceeds from financing arrangement, net of issuance costs						714,754
Proceeds from convertible notes payable and warrants						264,881
Repayment of debt					(1,015,189)	(363,365)
Deferred offering costs					5,925
Warrants issued in conjunction with debt						213,553
Issuance of common stock in conjunction with securities purchase agreement						262,500
Issuance of common stock from Equity Line of Credit, net of issuance costs					1,319,513
Issuance of common stock from At-The-Market Offering, net of issuance costs					6,849,817
Proceeds from issuance of Series C preferred stock – net of issuance costs						785,067
Net cash provided by financing activities					7,160,066	4,365,631
Net increase (decrease) in cash					(498,048)	155,036
Cash - beginning of period		$ 2,874,710		$ 155,647	2,874,710	155,647	$ 155,647
Cash - end of period	$ 2,376,662		$ 310,683		2,376,662	310,683	$ 2,874,710
Supplemental disclosure of non-cash investing and financing activities
Series A preferred dividends converted to common stock					223,167
Right of use asset obtained in exchange for operating lease					153,875
Convertible notes converted to common stock					654,333
Acquisition through issuance of Series D and Merger Warrants						75,000,000
Repayment of debt with investment						521,260
Forgiveness of note receivable and interest with note payable and interest from Acquisition						4,478,181
Issuance cost in conjunction with name change						56,667
Accrued Series A dividends					$ 18,600	$ 109,533

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash	$ 2,376,662	$ 2,874,710
Note receivable, net of allowance		199,000
Inventories, net		46,595
Prepaid expenses and other	1,220,980	1,163,078
Deferred offering costs	100,048	105,973
Interest receivable	4,623	698
Total current assets	3,702,313	4,390,054
Other assets
Fixed assets, net	1,506	3,673
Intangible assets, net	20,644,377	22,254,379
Right of use asset	126,259
Goodwill	7,565,680	7,565,680
Total other assets	28,337,822	29,823,732
Total assets	32,040,135	34,213,786
Current liabilities
Accounts payable	6,126,869	6,403,888
Accrued compensation	1,150,399	647,098
Accrued creator commissions	3,421,870	3,363,959
Settlement payable	1,621,096	1,714,385
Accrued expenses	602,397	1,004,540
Accrued expenses - related parties	309,333	309,333
Accrued sales tax	3,142,261	3,109,334
Deferred revenue	594,575	767,436
Convertible notes payable, net of discount	4,071,610	4,753,919
Notes payable, current portion, net of discount	1,768,945	2,370,907
Operating lease, current portion	75,678
Total current liabilities	22,885,033	24,444,799
Long-term liabilities
Operating lease, net of current portion	62,385
Total liabilities	22,947,418	24,444,799
Commitments and contingencies – Note 16
Stockholders’ equity
Common stock, $0.001 par value – 93,750,000 shares authorized at June 30, 2026 and December 31, 2025; 10,319,946 and 3,933,863 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	10,320	3,934
Additional paid-in capital	103,623,891	94,256,224
Accumulated deficit	(94,541,501)	(84,491,187)
Total stockholders’ equity	9,092,717	9,768,987
Total liabilities and stockholders’ equity	32,040,135	34,213,786
Series A Preferred Stock [Member]
Stockholders’ equity
Preferred stock, value		5
Series B Preferred Stock [Member]
Stockholders’ equity
Preferred stock, value	1	5
Series C Preferred Stock [Member]
Stockholders’ equity
Preferred stock, value	$ 6	$ 6